Skip to main content

Published locations for FDA advisory committee to consider adjuvant sunitinib for RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA advisory committee to consider adjuvant sunitinib for RCC

User login

  • Reset your password
  • /content/fda-advisory-committee-consider-adjuvant-sunitinib-rcc
  • /oncologypractice/article/144737/renal-cell-carcinoma/fda-advisory-committee-consider-adjuvant
  • /hematology-oncology/article/144737/renal-cell-carcinoma/fda-advisory-committee-consider-adjuvant